Literature DB >> 29264976

Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research.

Robert A Olson1,2,3, Fuchsia Howard2, Vincent Lapointe4, Devin Schellenberg4,5, Alan Nichol4, Gale Bowering6, Susan Curtis5, Allison Walter4, Steven Brown1, Corinne Thompson7, Jackie Bergin7, Sheri Lomas4, John French4, Ross Halperin7, Scott Tyldesley4, Wayne Beckham8.   

Abstract

The BC Cancer Agency Radiotherapy (RT) program started the Prospective Outcomes and Support Initiative (POSI) at all six centres to utilize patient-reported outcomes for immediate clinical care, quality improvement, and research. Patient-reported outcomes were collected at time of computed tomography simulation via tablet and 2 to 4 weeks post-RT via either tablet or over the phone by a registered nurse. From 2013 to 2016, patients were approached on 20,150 attempts by POSI for patients treated with RT for bone metastases (52%), brain metastases (11%), lung cancer (17%), gynecological cancer (16%), head and neck cancer (2%), and other pilots (2%). The accrual rate for all encounters was 85% (n = 17,101), with the accrual rate varying between the lowest and the highest accruing centre from 78% to 89% ( P < .001) and varying by tumour site ( P < .001). Using the POSI database, we have performed research and quality improvement initiatives that have changed practice.

Entities:  

Mesh:

Year:  2018        PMID: 29264976     DOI: 10.1177/0840470417715478

Source DB:  PubMed          Journal:  Healthc Manage Forum        ISSN: 0840-4704


  11 in total

1.  A novel carbon-fibre adjustable reusable accessory (CARA) for supine breast positioning to reduce toxicity in breast adjuvant radiotherapy: a study protocol for a multicentre phase III randomized controlled trial.

Authors:  Cheryl Duzenli; Elisa K Chan; Alanah M Bergman; Sheri Grahame; Joel Singer; Levi Burns; Robert A Olson
Journal:  BMC Cancer       Date:  2022-06-20       Impact factor: 4.638

Review 2.  Striving to Fill in Gaps between Clinical Practice and Standards: The Evolution of a Pan-Canadian Approach to Patient-Reported Outcomes Use.

Authors:  Amanda Caissie; Robert Olson; Lisa Barbera; Jennifer O'Donnell; Carol-Anne Davis; Jennifer Croke; Louise Bird; John Kildea; Erika Brown; Michael Brundage; Michael Milosevic
Journal:  Curr Oncol       Date:  2022-05-19       Impact factor: 3.109

3.  Validation of the BC-Brain Patient-Reported Outcome Questionnaire for Patients with Central Nervous System Tumours Treated with Radiotherapy.

Authors:  Ling Yan; Alan Nichol; Robert Olson
Journal:  Curr Oncol       Date:  2022-04-16       Impact factor: 3.109

4.  Patient-Reported Outcome Measures (PROMs) to Support Adherence to Falls Prevention Clinic Recommendations: A Qualitative Study.

Authors:  Daria Tai; Eric Li; Teresa Liu-Ambrose; Nick Bansback; Mohsen Sadatsafavi; Jennifer C Davis
Journal:  Patient Prefer Adherence       Date:  2020-10-30       Impact factor: 2.711

5.  Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers.

Authors:  Matthew Chan; Robert Olson; Vincent Lapointe; Jeremy Hamm; Francois Bachand; Caroline Holloway; Christina Parsons; Peter Lim
Journal:  Curr Oncol       Date:  2022-05-05       Impact factor: 3.109

6.  Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.

Authors:  W Y Cheung; P Kavan; A Dolley
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

7.  A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes.

Authors:  S Ahmed; L Barbera; S J Bartlett; D G Bebb; M Brundage; S Bryan; W Y Cheung; N Coburn; T Crump; L Cuthbertson; D Howell; A F Klassen; S Leduc; M Li; N E Mayo; G McKinnon; R Olson; J Pink; J W Robinson; M J Santana; R Sawatzky; R S Moxam; S Sinclair; F Servidio-Italiano; W Temple
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

8.  Validation of a Patient-Reported Outcome Measure for Moist Desquamation among Breast Radiotherapy Patients.

Authors:  Cheryl Duzenli; Elisa K Chan; Theodora Koulis; Sheri Grahame; Joel Singer; David Morris; Josslynn Spence; Terry Lee; Levi Burns; Robert A Olson
Journal:  Curr Oncol       Date:  2022-07-07       Impact factor: 3.109

9.  Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.

Authors:  Robert Olson; Mitchell Liu; Alanah Bergman; Sonya Lam; Fred Hsu; Benjamin Mou; Tanya Berrang; Ante Mestrovic; Nick Chng; Derek Hyde; Quinn Matthews; Chad Lund; Daniel Glick; Howard Pai; Parminder Basran; Hannah Carolan; Boris Valev; Shilo Lefresene; Scott Tyldesley; Devin Schellenberg
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430

10.  Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System.

Authors:  Robert A Olson; Vincent LaPointe; Alex Benny; Matthew Chan; Shilo Lefresne; Michael McKenzie
Journal:  Curr Oncol       Date:  2022-03-18       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.